Vanguard Group Inc Ani Pharmaceuticals Inc Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,181,471 shares of ANIP stock, worth $69.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,181,471
Previous 1,314,372
10.11%
Holding current value
$69.4 Million
Previous $72.7 Million
8.86%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ANIP
# of Institutions
239Shares Held
20.2MCall Options Held
7.4KPut Options Held
12.4K-
Black Rock Inc. New York, NY2.66MShares$156 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny818KShares$48.1 Million0.03% of portfolio
-
Global Alpha Capital Management Ltd.736KShares$43.2 Million3.53% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il723KShares$42.5 Million0.01% of portfolio
-
State Street Corp Boston, MA715KShares$42 Million0.0% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.02B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...